Login / Signup

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).

Michael B AtkinsOpeyemi A JegedeNaomi B HaasDavid F McDermottMehmet Asim BilenMark SteinJeffrey A SosmanRobert AlterElizabeth R PlimackMoshe C OrnsteinMichael HurwitzDavid J PeaceSabina SignorettiThomas DenizeAlessia CimadamoreCatherine J WuDavid A BraunDavid EinsteinPaul J CatalanoHans Hammers
Published in: Journal for immunotherapy of cancer (2023)
NCT03117309.
Keyphrases
  • phase ii study
  • open label
  • locally advanced
  • squamous cell carcinoma
  • clinical trial
  • randomized controlled trial
  • study protocol